Massive malaria vaccine trial shows promise for protecting young children
NCT ID NCT03855995
First seen Mar 10, 2026 · Last updated May 28, 2026 · Updated 8 times
Summary
This study tested the RTS,S/AS01E malaria vaccine in nearly 78,000 young children across Sub-Saharan Africa. Researchers monitored the vaccine's safety after routine use and measured how well it prevents malaria. The goal was to see if the vaccine can be safely added to regular childhood immunization programs to reduce malaria cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Kintampo, Ghana
-
GSK Investigational Site
Navrongo, Ghana
-
GSK Investigational Site
Kisumu, 4 0100, Kenya
-
GSK Investigational Site
Kisumu, 40100, Kenya
-
GSK Investigational Site
Chikwawa, Malawi
-
GSK Investigational Site
Mangochi, Malawi
Conditions
Explore the condition pages connected to this study.